Income Statement Mitani Corporation OTC Markets

Stocks

MITCF

JP3886800006

Construction Materials

Market Closed - OTC Markets Other stock markets 20:19:24 22/05/2025 +03			5-day change	1st Jan Change
13.17 ^USD	+2.73%		-.--%	-

25/12/24	Tranche Update on Mitani Corporation's Equity Buyback Plan announced on November 14, 2024.	CI
24/12/24	Mitani Corporation's Equity Buyback announced on November 14, 2024, has closed with 922,000 shares, representing 1.09% for ¥1,733.36 million.	CI

1b31e6f1240fee423f540b0c4.OP7ksA3jlQ9PBwfUTJNPUj8qOXCB8eXVrMiDuT9I5oo.X7DV9mWQw2MAN0XiDb4KO3d4ZjLih7OF6J7X1H1x1L1Ph9WFRoT5fQNkaA

Published financial data: MITANI CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	299B	320B	325B	339B	339B
Total Revenues	299B	320B	325B	339B	339B
Cost of Goods Sold, Total	252B	271B	270B	279B	276B
Gross Profit	46.93B	49.59B	54.36B	60.19B	62.63B
Selling General & Admin Expenses, Total	24.15B	25.9B	26.11B	26.81B	28.09B
Provision for Bad Debts	-	-	-	-	-
R&D Expenses	68M	75M	84M	98M	105M
Depreciation & Amortization - (IS)	2.06B	1.94B	2.34B	1.77B	2.05B
Other Operating Expenses, Total	26.27B	27.92B	28.53B	28.68B	30.24B
Operating Income	20.66B	21.68B	25.83B	31.51B	32.39B
Interest Expense, Total	-89M	-121M	-193M	-193M	-172M
Interest And Investment Income	260M	222M	935M	780M	856M
Net Interest Expenses	171M	101M	742M	587M	684M
Income (Loss) On Equity Invest.	-	992M	1.14B	847M	1.77B
Currency Exchange Gains (Loss)	663M	550M	1.16B	-	538M
Other Non Operating Income (Expenses)	1.2B	1.03B	850M	677M	1.25B
EBT, Excl. Unusual Items	22.69B	24.35B	29.72B	33.62B	36.63B
Gain (Loss) On Sale Of Investments	44M	-	176M	53M	162M
Gain (Loss) On Sale Of Assets	-239M	-	-	224M	-40M
Asset Writedown	-583M	-363M	-774M	-1.02B	-75M
Other Unusual Items	-253M	-70M	283M	-1.46B	69M
EBT, Incl. Unusual Items	21.66B	23.91B	29.4B	31.42B	36.75B
Income Tax Expense	6.83B	7.12B	9.09B	9.82B	10.61B
Earnings From Continuing Operations	14.83B	16.8B	20.31B	21.6B	26.14B
Net Income to Company	14.83B	16.8B	20.31B	21.6B	26.14B
Minority Interest	-1.75B	-1.93B	-2.14B	-2.58B	-2.69B
Net Income - (IS)	13.08B	14.86B	18.17B	19.02B	23.45B
Net Income to Common Incl Extra Items	13.08B	14.86B	18.17B	19.02B	23.45B
Net Income to Common Excl. Extra Items	13.08B	14.86B	18.17B	19.02B	23.45B
Per Share Items
Net EPS - Basic	139.45	165.6	203.62	222.44	280.44
Basic EPS - Continuing Operations	139.45	165.6	203.62	222.44	280.44
Basic Weighted Average Shares Outstanding	93.77M	89.76M	89.22M	85.51M	83.63M
Net EPS - Diluted	139.4	165.54	203.55	222.36	280.34
Diluted EPS - Continuing Operations	139.4	165.54	203.55	222.36	280.34
Diluted Weighted Average Shares Outstanding	93.81M	89.79M	89.26M	85.55M	83.66M
Normalized Basic EPS	132.53	148.01	184.14	215.59	241.65
Normalized Diluted EPS	132.48	147.95	184.07	215.51	241.55
Dividend Per Share	34	40	55	66	97
Payout Ratio	24	22.21	24.14	28.85	28.17
Supplemental Items
EBITDA	25.97B	27.02B	31.57B	36.97B	38.05B
EBITA	21.18B	22.13B	26.57B	32B	32.89B
EBIT	20.66B	21.68B	25.83B	31.51B	32.39B
EBITDAR	27.96B	29.02B	33.59B	38.98B	40.03B
Effective Tax Rate - (Ratio)	31.53	29.77	30.92	31.26	28.87
Normalized Net Income	12.43B	13.29B	16.43B	18.44B	20.21B
Non-Cash Pension Expense	-614M	-32M	-137M	-895M	-285M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	68M	75M	84M	98M	105M
Net Rental Expense, Total	1.99B	2B	2.02B	2.01B	1.98B
Imputed Operating Lease Interest Expense	159M	227M	399M	406M	313M
Imputed Operating Lease Depreciation	1.83B	1.77B	1.62B	1.6B	1.67B

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	89.9B	100B	120B	128B	141B
Total Cash And Short Term Investments	89.9B	100B	120B	128B	141B
Accounts Receivable, Total	82.27B	87.2B	92.11B	86.67B	85.88B
Total Receivables	82.27B	87.2B	92.11B	86.67B	85.88B
Inventory	11.8B	14.51B	16.55B	16.22B	16.33B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	7.79B	7.78B	8.95B	9.54B	10.38B
Total Current Assets	192B	210B	238B	241B	253B
Net Property Plant And Equipment	37.96B	39.45B	37.65B	34.16B	35.29B
Long-term Investments	17.02B	16.61B	19.55B	19.84B	23.3B
Goodwill	887M	2.51B	1.72B	1.52B	1.09B
Other Intangibles, Total	1.35B	1.25B	994M	1.13B	1.47B
Loans Receivable Long-Term	92M	92M	98M	98M	97M
Deferred Tax Assets Long-Term	1.23B	1.21B	1.21B	1.35B	1.35B
Other Long-Term Assets, Total	2M	1M	1M	1M	2M
Total Assets	250B	271B	299B	299B	316B
Liabilities
Accounts Payable, Total	57.91B	60.63B	71.2B	62.92B	62.83B
Accrued Expenses, Total	2.25B	2.26B	2.33B	2.46B	2.77B
Short-term Borrowings	4.76B	6.07B	6.16B	6.64B	7.02B
Current Income Taxes Payable	3.43B	3.61B	5.78B	5.7B	5.98B
Other Current Liabilities	12.96B	17.04B	17.21B	17.91B	15.04B
Total Current Liabilities	81.32B	89.62B	103B	95.62B	93.64B
Long-Term Debt	3.68B	2.55B	822M	1.67B	2.11B
Pension & Other Post Retirement Benefits	2.43B	2.41B	2.49B	2.48B	2.39B
Deferred Tax Liability Non Current	1.47B	1.84B	2.34B	2.09B	2.93B
Other Non Current Liabilities	5.26B	5.2B	5.23B	4.96B	5.11B
Total Liabilities	94.17B	102B	114B	107B	106B
Common Stock, Total	5.01B	5.01B	5.01B	5.01B	5.01B
Additional Paid In Capital	3.61B	3.68B	4.04B	-	1.83B
Retained Earnings	150B	162B	175B	164B	181B
Treasury Stock	-23.16B	-24.93B	-26.44B	-6.97B	-6.98B
Comprehensive Income and Other	1.09B	2.2B	3.97B	4.89B	6.17B
Total Common Equity	136B	147B	162B	167B	187B
Minority Interest	19.68B	21.85B	23.62B	24.99B	22.66B
Total Equity	156B	169B	186B	192B	210B
Total Liabilities And Equity	250B	271B	299B	299B	316B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	90.51M	89.3M	88.48M	83.65M	83.62M
ECS Total Common Shares Outstanding	90.51M	89.3M	88.48M	83.65M	83.62M
Book Value / Share	1.51K	1.65K	1.83K	2K	2.24K
Tangible Book Value	134B	144B	159B	165B	185B
Tangible Book Value Per Share	1.48K	1.61K	1.8K	1.97K	2.21K
Total Debt	8.45B	8.62B	6.98B	8.31B	9.13B
Net Debt	-81.46B	-91.71B	-113B	-120B	-132B
Debt Equivalent of Unfunded Proj. Benefit Obligation	206M	15M	-900M	-1.26B	-2.52B
Debt Equivalent Oper. Leases	15.94B	16B	16.15B	16.07B	15.88B
Minority Interest, Total (Incl. Fin. Div)	19.68B	21.85B	23.62B	24.99B	22.66B
Inventories - Raw Materials, Total	2.46B	2.89B	3.54B	4.11B	5.59B
Inventories - Work In Process, Total	1.9B	2.17B	1.89B	1.18B	1.25B
Inventories - Finished Goods, Total	7.44B	9.46B	11.12B	10.93B	9.48B
Full Time Employees	2K	2.06K	2.06K	2.08K	2.1K
Accumulated Allowance for Doubtful Accounts (Supple)	46M	117M	53M	86M	141M

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	21.66B	23.91B	29.4B	31.42B	36.75B
Depreciation & Amortization - CF	4.79B	4.89B	5B	4.98B	5.16B
Amortization of Goodwill and Intangible Assets - (CF)	519M	452M	744M	487M	499M
Depreciation & Amortization, Total	5.31B	5.34B	5.74B	5.46B	5.66B
(Gain) Loss From Sale Of Asset	311M	44M	507M	1.02B	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	32M	-992M	-1.14B	-847M	-1.77B
Other Operating Activities, Total	-7.06B	-6.5B	-6.94B	-9.47B	-9.89B
Change In Accounts Receivable	-6.07B	-3.82B	-4.34B	6.41B	994M
Change In Inventories	-2.64B	-1.74B	-1.72B	892M	-67M
Change In Accounts Payable	5.46B	2.34B	10.48B	-8.41B	-115M
Change in Other Net Operating Assets	-212M	2.02B	-402M	-1.07B	-3.67B
Cash from Operations	16.79B	20.6B	31.58B	25.42B	27.9B
Capital Expenditure	-4.91B	-2.57B	-4.59B	-4.5B	-6.3B
Sale of Property, Plant, and Equipment	19M	42M	136M	1.91B	75M
Cash Acquisitions	-	-2.98B	-	-	-
Divestitures	-	12M	-	-	-
Investment in Marketable and Equity Securities, Total	-206M	-13.44B	-6.32B	-1.75B	-2.38B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-2M	-	-	-	-
Other Investing Activities, Total	-362M	-525M	-460M	-567M	-818M
Cash from Investing	-5.46B	-19.46B	-11.24B	-4.91B	-9.42B
Short Term Debt Issued, Total	-	38M	-	1.72B	598M
Long-Term Debt Issued, Total	-	-	-	-	1.55B
Total Debt Issued	-	38M	-	1.72B	2.15B
Short Term Debt Repaid, Total	-49M	-	-447M	-	-
Long-Term Debt Repaid, Total	-1.1B	-1.13B	-1.52B	-2.65B	-1.28B
Total Debt Repaid	-1.15B	-1.13B	-1.97B	-2.65B	-1.28B
Repurchase of Common Stock	-10.15B	-757M	-1.51B	-7.91B	-
Common Dividends Paid	-3.14B	-3.3B	-4.38B	-5.49B	-6.61B
Common & Preferred Stock Dividends Paid	-3.14B	-3.3B	-4.38B	-5.49B	-6.61B
Other Financing Activities, Total	-808M	-341M	-313M	-658M	-3.32B
Cash from Financing	-15.25B	-5.49B	-8.18B	-14.99B	-9.06B
Foreign Exchange Rate Adjustments	585M	1.09B	1.07B	921M	288M
Miscellaneous Cash Flow Adjustments	51M	151M	-	-1M	53M
Net Change in Cash	-3.29B	-3.12B	13.23B	6.44B	9.76B
Supplemental Items
Cash Interest Paid	80M	131M	183M	211M	167M
Cash Income Tax Paid (Refund)	7.22B	6.64B	7.12B	9.87B	10.34B
Levered Free Cash Flow	8.32B	15.6B	22.01B	18.19B	16.97B
Unlevered Free Cash Flow	8.38B	15.68B	22.13B	18.31B	17.08B
Change In Net Working Capital	4.93B	642M	-4.84B	2.34B	2.52B
Net Debt Issued / Repaid	-1.15B	-1.09B	-1.97B	-930M	867M

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	5.23	5.2	5.66	6.59	6.58
Return on Total Capital	7.87	7.91	8.72	10.02	9.65
Return On Equity %	9.56	10.32	11.45	11.44	13
Return on Common Equity	9.6	10.47	11.74	11.56	13.24
Margin Analysis
Gross Profit Margin %	15.68	15.48	16.74	17.75	18.47
SG&A Margin	8.07	8.09	8.04	7.91	8.28
EBITDA Margin %	8.67	8.44	9.72	10.91	11.22
EBITA Margin %	7.07	6.91	8.18	9.44	9.7
EBIT Margin %	6.9	6.77	7.95	9.29	9.55
Income From Continuing Operations Margin %	4.95	5.24	6.25	6.37	7.71
Net Income Margin %	4.37	4.64	5.59	5.61	6.92
Net Avail. For Common Margin %	4.37	4.64	5.59	5.61	6.92
Normalized Net Income Margin	4.15	4.15	5.06	5.44	5.96
Levered Free Cash Flow Margin	2.78	4.87	6.78	5.37	5.01
Unlevered Free Cash Flow Margin	2.8	4.9	6.82	5.4	5.04
Asset Turnover
Asset Turnover	1.21	1.23	1.14	1.13	1.1
Fixed Assets Turnover	7.9	8.27	8.42	9.44	9.76
Receivables Turnover (Average Receivables)	3.78	3.78	3.62	3.79	3.93
Inventory Turnover (Average Inventory)	24.21	20.58	17.41	17.01	16.98
Short Term Liquidity
Current Ratio	2.36	2.34	2.32	2.52	2.71
Quick Ratio	2.12	2.09	2.07	2.25	2.42
Operating Cash Flow to Current Liabilities	0.21	0.23	0.31	0.27	0.3
Days Sales Outstanding (Average Receivables)	96.45	96.57	101.04	96.24	92.88
Days Outstanding Inventory (Average Inventory)	15.08	17.74	21.02	21.45	21.49
Average Days Payable Outstanding	78.88	79.13	88.54	87.89	83
Cash Conversion Cycle (Average Days)	32.65	35.17	33.51	29.81	31.38
Long Term Solvency
Total Debt/Equity	5.41	5.09	3.76	4.32	4.35
Total Debt / Total Capital	5.13	4.85	3.63	4.15	4.17
LT Debt/Equity	2.36	1.51	0.44	0.87	1.01
Long-Term Debt / Total Capital	2.24	1.44	0.43	0.83	0.96
Total Liabilities / Total Assets	37.62	37.51	37.97	35.73	33.59
EBIT / Interest Expense	232.1	179.13	133.83	163.26	188.31
EBITDA / Interest Expense	291.75	223.28	163.58	191.56	221.22
(EBITDA - Capex) / Interest Expense	236.57	202.06	139.78	168.25	184.58
Total Debt / EBITDA	0.33	0.32	0.22	0.22	0.24
Net Debt / EBITDA	-3.14	-3.39	-3.59	-3.25	-3.46
Total Debt / (EBITDA - Capex)	0.4	0.35	0.26	0.26	0.29
Net Debt / (EBITDA - Capex)	-3.87	-3.75	-4.2	-3.7	-4.15
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-24.59	6.99	1.4	4.38	0.01
Gross Profit, 1 Yr. Growth %	1.19	5.68	9.6	10.73	4.06
EBITDA, 1 Yr. Growth %	2.86	4.05	16.85	17.11	2.92
EBITA, 1 Yr. Growth %	1.98	4.49	20.09	20.41	2.79
EBIT, 1 Yr. Growth %	2.61	4.93	19.16	21.99	2.79
Earnings From Cont. Operations, 1 Yr. Growth %	9.02	13.27	20.94	6.33	21.02
Net Income, 1 Yr. Growth %	5.02	13.67	22.22	4.71	23.29
Normalized Net Income, 1 Yr. Growth %	-4.64	6.9	23.67	12.22	9.61
Diluted EPS Before Extra, 1 Yr. Growth %	8.63	18.75	22.96	9.24	26.07
Accounts Receivable, 1 Yr. Growth %	8.33	6	5.63	-5.91	-0.91
Inventory, 1 Yr. Growth %	30.36	22.97	14.07	-1.98	0.63
Net Property, Plant and Equip., 1 Yr. Growth %	0.5	3.91	-4.55	-9.29	3.31
Total Assets, 1 Yr. Growth %	2.77	8.25	10.37	-0.02	5.71
Tangible Book Value, 1 Yr. Growth %	0.74	7.09	10.75	3.36	12.25
Common Equity, 1 Yr. Growth %	0.35	8.09	9.76	3.27	12
Cash From Operations, 1 Yr. Growth %	2.01	22.66	53.33	-19.52	9.78
Capital Expenditures, 1 Yr. Growth %	30.61	-47.71	78.86	-2.05	40.08
Levered Free Cash Flow, 1 Yr. Growth %	-12.08	87.47	41.08	-17.36	-6.7
Unlevered Free Cash Flow, 1 Yr. Growth %	-11.95	87.13	41.17	-17.26	-6.73
Dividend Per Share, 1 Yr. Growth %	8.8	17.65	37.5	20	46.97
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-14.82	-10.18	4.16	2.88	2.17
Gross Profit, 2 Yr. CAGR %	2.4	3.41	7.62	10.17	7.34
EBITDA, 2 Yr. CAGR %	4.95	3.45	10.26	16.98	9.78
EBITA, 2 Yr. CAGR %	4.53	3.23	12.02	20.25	11.25
EBIT, 2 Yr. CAGR %	4.85	3.76	11.82	20.57	11.98
Earnings From Cont. Operations, 2 Yr. CAGR %	10.3	11.12	17.04	13.4	13.44
Net Income, 2 Yr. CAGR %	11.91	9.26	17.87	13.13	13.62
Normalized Net Income, 2 Yr. CAGR %	7.08	0.97	14.98	17.8	10.91
Diluted EPS Before Extra, 2 Yr. CAGR %	15.09	13.58	20.84	15.9	17.36
Accounts Receivable, 2 Yr. CAGR %	7.01	7.16	5.81	-0.31	-3.44
Inventory, 2 Yr. CAGR %	16.77	26.61	18.43	5.74	-0.68
Net Property, Plant and Equip., 2 Yr. CAGR %	3.68	2.19	-0.41	-6.95	-3.19
Total Assets, 2 Yr. CAGR %	3.87	5.48	9.31	5.04	2.81
Tangible Book Value, 2 Yr. CAGR %	2.28	3.86	8.9	6.99	7.71
Common Equity, 2 Yr. CAGR %	2.18	4.15	8.92	6.46	7.55
Cash From Operations, 2 Yr. CAGR %	21.24	11.86	37.14	11.08	-6.01
Capital Expenditures, 2 Yr. CAGR %	0.59	-17.36	-3.29	32.36	17.14
Levered Free Cash Flow, 2 Yr. CAGR %	15.65	28.39	62.63	7.98	-12.19
Unlevered Free Cash Flow, 2 Yr. CAGR %	15.47	28.36	62.53	8.07	-12.15
Dividend Per Share, 2 Yr. CAGR %	11.19	13.14	27.19	28.45	32.8
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-10.52	-8.1	-6.47	4.23	1.91
Gross Profit, 3 Yr. CAGR %	1.93	3.48	5.43	8.65	8.09
EBITDA, 3 Yr. CAGR %	3.8	4.65	7.74	12.5	12.09
EBITA, 3 Yr. CAGR %	2.98	4.52	8.57	14.75	14.12
EBIT, 3 Yr. CAGR %	3.24	4.88	8.66	15.11	14.33
Earnings From Cont. Operations, 3 Yr. CAGR %	1.4	11.28	14.3	13.36	15.89
Net Income, 3 Yr. CAGR %	1.79	12.5	13.42	13.31	16.42
Normalized Net Income, 3 Yr. CAGR %	4.32	7.02	8.03	14.05	15.01
Diluted EPS Before Extra, 3 Yr. CAGR %	3.88	16.3	16.62	16.84	19.2
Accounts Receivable, 3 Yr. CAGR %	0.02	6.67	6.64	1.75	-0.51
Inventory, 3 Yr. CAGR %	7.22	18.8	22.28	11.2	4.01
Net Property, Plant and Equip., 3 Yr. CAGR %	3.06	3.75	-0.11	-3.46	-3.65
Total Assets, 3 Yr. CAGR %	1.12	5.31	7.08	6.1	5.27
Tangible Book Value, 3 Yr. CAGR %	3.62	3.86	6.11	7.02	8.72
Common Equity, 3 Yr. CAGR %	3.39	4.12	5.99	7	8.28
Cash From Operations, 3 Yr. CAGR %	-5.32	21.71	24.26	14.82	10.65
Capital Expenditures, 3 Yr. CAGR %	12.64	-19.12	6.9	-2.88	34.88
Levered Free Cash Flow, 3 Yr. CAGR %	-19.23	35.85	32.49	29.78	2.85
Unlevered Free Cash Flow, 3 Yr. CAGR %	-19.17	35.63	32.5	29.78	2.9
Dividend Per Share, 3 Yr. CAGR %	24.78	13.3	20.74	24.74	34.35
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-3.7	-3.36	-4.91	-3.85	-3.11
Gross Profit, 5 Yr. CAGR %	2.87	3.78	4.17	6.11	6.19
EBITDA, 5 Yr. CAGR %	5.02	5.37	6.34	9.42	8.55
EBITA, 5 Yr. CAGR %	4.79	5.3	6.51	10.55	9.63
EBIT, 5 Yr. CAGR %	4.69	5.58	6.59	10.89	9.98
Earnings From Cont. Operations, 5 Yr. CAGR %	4.01	7.42	7.39	12.12	13.96
Net Income, 5 Yr. CAGR %	4.57	8.45	7.94	12.75	13.5
Normalized Net Income, 5 Yr. CAGR %	5.82	7.77	8.46	11.21	9.17
Diluted EPS Before Extra, 5 Yr. CAGR %	6.58	11.03	10.36	16.14	16.92
Accounts Receivable, 5 Yr. CAGR %	1.45	1.9	2.3	3.82	2.49
Inventory, 5 Yr. CAGR %	19.71	16.29	11.57	13.39	12.52
Net Property, Plant and Equip., 5 Yr. CAGR %	1.89	2.78	1.66	-0.67	-1.35
Total Assets, 5 Yr. CAGR %	4.34	3.76	4.32	5.2	5.35
Tangible Book Value, 5 Yr. CAGR %	4.96	5.36	5.7	5.1	6.75
Common Equity, 5 Yr. CAGR %	5.05	5.35	5.57	5.05	6.61
Cash From Operations, 5 Yr. CAGR %	4.03	-4.81	9.8	17.34	11.13
Capital Expenditures, 5 Yr. CAGR %	8.02	-12.62	5.98	-1.51	10.88
Levered Free Cash Flow, 5 Yr. CAGR %	-12.7	2.02	6.87	23.93	12.39
Unlevered Free Cash Flow, 5 Yr. CAGR %	-12.64	2.03	6.89	23.85	12.41
Dividend Per Share, 5 Yr. CAGR %	29.05	26.7	25.74	19.14	25.43